- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01692600
Optical Coherence Tomography for Monitoring Late Oral Radiation Toxicity After Radiotherapy of Head and Neck Cancer Patients
Study Overview
Status
Conditions
Detailed Description
Patient imaging
At the imaging session, the patient will be asked to sit on the chair and put her/his chin on the chin-rest and the height of the chair will be adjusted accordingly. Before turning on the light source, the patient will be asked to wear the safety goggles and open her/his mouth while the probe is slowly moved inside the oral cavity. At this point, by looking at the superficial oral tissue, we will find regions in the oral cavity with superficial changes. When such regions are found, OCT images of these regions will be taken. Imaging of each location is expected to take about 3 to 4 minutes (including the time required to find the region of interest, acquisition of structural, Doppler and speckle variance images, and the time between each of these processes). After this, the patient can close her/his mouth and rest for couple of minutes. The same procedure will be performed on another site of complication. The 3-4 minute imaging procedure is repeated 3 to 5 times (depending on the patients' ability to keep the mouth open), after which the patient is dismissed and the sterile probe cover will be disposed. All the acquired data will be stored in a computer which is kept in a locked office. The data will be processed within the week after the imaging session so that structural, Doppler and speckle variance images of the imaged sites of complication can be compared.
During imaging, structural OCT real-time images are shown on the monitor to facilitate the task of finding the region of interest and keeping track of the patient's movements and move the probe accordingly. During the Doppler or speckle variance imaging (approximately 7 seconds each within the 3-4 minutes interval mentioned before), the patient is asked to keep as still as possible, in order to avoid any motion artifact in the OCT images.
Note that time frame for this study is 1 day, since subjects are only imaged once with no follow-up assessments.
Imaging healthy volunteers
The imaging session of the volunteers takes between 30 to 60 minutes. The imaging procedure of these healthy volunteers is very similar to that explained for the patients; however, all the acquired OCT images of this group would be of healthy oral tissue.
Note that time frame for this study is 1 day, since the volunteers are only imaged once with no follow-up assessments.
**Important note: The aim of this study is to compare the images from patients with those of healthy volunteers and show that there are specific changes in the structural and vascular features of the patients (due to radiation toxicity) when compared to the volunteers. So, the comparison is done between the two cohorts of the study.
Data analysis
For the healthy volunteers, the gathered OCT data will be processed to form structural, Doppler and speckle variance images of healthy oral tissue to serve as a reference. The same procedure will be performed on late oral radiation toxicity patients to reconstruct structural, Doppler and speckle variance images of the site of oral complications. Then, the images of healthy volunteers and patients will be compared in terms of the layer thickness, the back-reflection properties of each layer, and the size and profile of blood flow of the microvasculature. In order to compare these two sets of images quantitatively, certain metrics will be defined based on the images of the healthy volunteers. All these quantitative comparisons of healthy oral tissue and tissue with radiation complication will be used to form an OCT atlas of oral radiation toxicity. Moreover, white-light images of the regions of OCT study will be taken in order to serve as a reference for the superficial complications caused by radiation.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1L7
- Princess Margaret Hospital/UHNTorotno
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
for the patients:
- Must have undergone radiation therapy of the head and neck site
- Must have developed some form of late oral radiation toxicity
- Attending the radiation late effects clinic at Princess Margaret Cancer Center, Toronto, Canada
For the healthy volunteers:
1- Generally healthy
Exclusion criteria for the patients:
- Unable to keep the mouth open for more than 3 minutes
- Unable to open the mouth more than 2cm (to admit the OCT probe)
- Having loose teeth
for the healthy volunteers:
- Having an oral infection or disease
- Unable to keep the mouth open continuously for 5 minutes
- Unable to open the mouth more than 2cm
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
|---|
|
healthy volunteers
Age-matched with the patient group, with no oral pathologies and comorbidities
|
|
Late oral radiation toxicity patients
Head-and-neck cancer patients who had undergone radiation therapy and developed late radiation side ffects
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison between the oral layer structure of radiation toxicity patients and healthy volunteers as shown in the OCT structural images
Time Frame: at the imaging time point [comparison between cohorts]
|
Structural OCT images of the oral tissue of the late radiation toxicity patients will be taken and will be processed to highlight any differences between them and the healthy human oral tissue.
An example of the expected differences (in the patients compared to healthy volunteers) is total loss of basal layer and thus loss of differentiation between epithelium and lamina propria in the patients.
|
at the imaging time point [comparison between cohorts]
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison between vascular structure and blood flow properties in the vascular OCT images of radiation toxicity patients and healthy volunteers as shown in the OCT vascular images
Time Frame: At the imaging time point [comparison between cohorts]
|
Doppler OCT and speckle variance OCT images will be taken to reveal information on the blood flow and vascular structure, respectively.
These images will be processed and information about the blood flow, size of the vasculature, and vessel density of the radiation toxicity patients will be extracted and the average values will be compared to those of healthy human volunteer cases
|
At the imaging time point [comparison between cohorts]
|
Collaborators and Investigators
Investigators
- Principal Investigator: Alex I Vitkin, PhD, University of Toronto/UHNToronto
Publications and helpful links
General Publications
- Davoudi B, Lindenmaier A, Standish BA, Allo G, Bizheva K, Vitkin A. Noninvasive in vivo structural and vascular imaging of human oral tissues with spectral domain optical coherence tomography. Biomed Opt Express. 2012 May 1;3(5):826-39. doi: 10.1364/BOE.3.000826. Epub 2012 Apr 2.
- Davoudi B, Morrison M, Bizheva K, Yang VX, Dinniwell R, Levin W, Vitkin IA. Optical coherence tomography platform for microvascular imaging and quantification: initial experience in late oral radiation toxicity patients. J Biomed Opt. 2013 Jul;18(7):76008. doi: 10.1117/1.JBO.18.7.076008.
- Davoudi B, Bizheva K, Wong A, Dinniwell R, Levin L and Vitkin A. Correlating optical coherence tomography images with dose distribution in late oral radiation toxicity patients. Photonics and Lasers in Medicine 3(4): 311-321, 2014
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12-0095-CE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abnormalities, Radiation-Induced
-
State University of New York - Upstate Medical...Carol M. Baldwin Breast Cancer Research Fund, Inc.TerminatedAbnormalities, Radiation-InducedUnited States
-
UPECLIN HC FM Botucatu UnespCompletedAbnormalities, Radiation-InducedBrazil
-
Institute of Oncology LjubljanaCompletedRadiation Necrosis | Radiation Injury | Radiation-Induced ComplicationsSlovenia
-
National Cancer Institute (NCI)CompletedRadiation-Induced Neoplasms | Breast+Neoplasm+Radiation+Etiology | Thyroid+Neoplasm+Radiation+EtiologyUnited States
-
McMaster UniversityNot yet recruitingOxidative Stress | Radiation Exposure | DNA Damage, Radiation Induced
-
Zhejiang Cancer HospitalNot yet recruitingChronic Radiation Induced Intestinal Injury | Chronic Radiation EnteritisChina
-
University of AarhusAarhus University Hospital; The University of New South Wales; South Eastern... and other collaboratorsRecruitingLung Cancer | Pulmonary Disease | Radiation Pneumonitis | Lung Function Decreased | Radiation-Induced DisorderDenmark, Australia
-
Alexandria UniversityRecruitingRadiation Induced XerostomiaEgypt
-
Apeiron BiologicsCompleted
-
Pharm Olam Pharmaceuticals Ltd.UnknownPrevention of Radiation Induced Dermatitis.